// App-Quantinova.ai

1191 : Anti-tumor effect of selective progesterone receptor modulator (ulipristal acetate) on endometrial cancer cell lines

Researchers

Presenter

  • Ha-Young Lee

Principal Investigators

  • Dong-Woo Kang

  • Yu-Seon Kim

  • Su-Min Kim

  • Tae-Wook Kang

  • Shin-Wha Lee

  • Yong-Man Kim

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Endometrial Cancer

  • Diabetes

  • Uterine fibroids

  • Breast cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • Progesterone receptor

Drug/Treatment

  • Uliprisnil acetate

  • Mifepristone

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved